Outpatient Registry Trial of Respiratory Tract Infections in Adults

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2005

Study Completion Date

July 31, 2006

Conditions
Pneumonia, BacterialBronchitis, Chronic
Interventions
DRUG

azithromycin

250 mg tablets; 2 tablets on day 1 (500 mg load) and 1 tablet QD on days 2-5

DRUG

telithromycin

400 mg tablets; 2 tablets once daily (QD) for 5 days

DRUG

Clarythromycin

500 mg extended release tablets; 2 tablets QD for 7 days

Trial Locations (2)

42240

Western Kentucky Pulmonary Clinic, Louisville

70461

Northshore Research Associates, Slidell

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

CPL Associates

OTHER